Security key
71722W107
Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT)
CUSIP: 71722W107
Q1 2020 13F Holders as of 31 Mar 2020
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 78,837,943
- Total 13F shares
- 21,949,381
- Share change
- +139,226
- Total reported value
- $565,607,078
- Price per share
- $25.82
- Number of holders
- 47
- Value change
- +$3,219,839
- Number of buys
- 25
- Number of sells
- 17
Report period
Q1 2020
Institutions
47
Top holders
10
PHAT full security history
Newer quarter: Q2 2020
Previous quarter: Q4 2019
Phathom Pharmaceuticals, Inc. SEC filings
Phathom Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 71722W107
Recent filing periods:
Top shareholders of PHAT - Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FRAZIER MANAGEMENT LLC |
13F
|
Company |
9.2%
|
7,284,269
|
$226,832,000 | — | 31 Dec 2019 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
4.6%
|
3,646,808
|
$113,562,000 | — | 31 Dec 2019 | |
| Invesco Ltd. |
13F
|
Company |
2.7%
|
2,102,303
|
$65,466,000 | — | 31 Dec 2019 | |
| Medicxi Ventures Management (Jersey) Ltd |
13F
|
Company |
2.6%
|
2,067,861
|
$64,393,000 | — | 31 Dec 2019 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.9%
|
1,467,462
|
$43,589,000 | — | 31 Dec 2019 | |
| Abingworth LLP |
13F
|
Company |
1.5%
|
1,203,135
|
$37,430,000 | — | 31 Dec 2019 | |
| BVF INC/IL |
13F
|
Company |
1%
|
785,851
|
$24,471,000 | — | 31 Dec 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.81%
|
640,715
|
$19,952,000 | — | 31 Dec 2019 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.78%
|
616,857
|
$19,208,000 | — | 31 Dec 2019 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.57%
|
450,000
|
$14,013,000 | — | 31 Dec 2019 | |
| Greenspring Associates, LLC |
13F
|
Company |
0.46%
|
360,939
|
$11,240,000 | — | 31 Dec 2019 | |
| NORGES BANK |
13F
|
Company |
0.4%
|
317,300
|
$9,881,000 | — | 31 Dec 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.26%
|
205,995
|
$6,415,000 | — | 31 Dec 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.19%
|
153,434
|
$4,777,000 | — | 31 Dec 2019 | |
| STATE STREET CORP |
13F
|
Company |
0.16%
|
125,243
|
$3,900,000 | — | 31 Dec 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.15%
|
114,426
|
$3,563,000 | — | 31 Dec 2019 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.09%
|
67,787
|
$2,111,000 | — | 31 Dec 2019 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.04%
|
35,345
|
$1,100,000 | — | 31 Dec 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.03%
|
24,794
|
$772,000 | — | 31 Dec 2019 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.03%
|
23,141
|
$721,000 | — | 31 Dec 2019 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
16,437
|
$512,000 | — | 31 Dec 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
14,441
|
$450,000 | — | 31 Dec 2019 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
14,099
|
$439,000 | — | 31 Dec 2019 | |
| Athanor Capital, LP |
13F
|
Company |
0.02%
|
13,373
|
$416,000 | — | 31 Dec 2019 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
9,700
|
$302,000 | — | 31 Dec 2019 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.01%
|
7,528
|
$234,000 | — | 31 Dec 2019 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.01%
|
6,986
|
$218,000 | — | 31 Dec 2019 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
6,738
|
$210,000 | — | 31 Dec 2019 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.01%
|
6,492
|
$202,000 | — | 31 Dec 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0%
|
3,926
|
$121,000 | — | 31 Dec 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
3,509
|
$109,000 | — | 31 Dec 2019 | |
| STRS OHIO |
13F
|
Company |
0%
|
2,800
|
$87,000 | — | 31 Dec 2019 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
2,158
|
$67,000 | — | 31 Dec 2019 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
2,117
|
$66,000 | — | 31 Dec 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
1,855
|
$58,000 | — | 31 Dec 2019 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0%
|
1,352
|
$42,000 | — | 31 Dec 2019 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
925
|
$29,000 | — | 31 Dec 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
876
|
$27,000 | — | 31 Dec 2019 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
693
|
$22,000 | — | 31 Dec 2019 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0%
|
85
|
$3,000 | — | 31 Dec 2019 |
Institutional Holders of Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT) as of Q1 2020
As of 31 Mar 2020,
Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,949,381 shares.
The largest 10 holders included
FRAZIER MANAGEMENT LLC, RA CAPITAL MANAGEMENT, L.P., Invesco Ltd., Medicxi Ventures Management (Jersey) Ltd, JANUS HENDERSON GROUP PLC, Abingworth LLP, BVF INC/IL, Ensign Peak Advisors, Inc, BlackRock Inc., and EVENTIDE ASSET MANAGEMENT, LLC.
This page lists
47
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2020 vs Q4 2019 Across Filers
Q4 2019 holders
40
Q1 2020 holders
47
Holder diff
7
| Investor | Q4 2019 Shares | Q1 2020 Shares | Share Diff | Share Chg % | Q4 2019 Value $ | Q1 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.